Health Care & Life Sciences » Pharmaceuticals | Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.39
Market Cap
$737.79 M
Shares Outstanding
52.96 M
Public Float
51.15 M

Profile

Address
2200 Pennsylvania Avenue NW
Washington District of Columbia 20037
United States
Employees -
Website http://www.vandapharma.com
Updated 07/08/2019
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051.

Financials

View All
Created with Highcharts 5.0.14Vanda Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.20 25520 25520 18620 18639 86539 86518 01018 01015 56715 56725 20825 208201320142015201620172018010k20k30k40k50k
Created with Highcharts 5.0.14Vanda Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.33 87933 87950 15750 157109 925109 925146 017146 017165 083165 083193 118193 118201320142015201620172018050k100k150k200k250k

Mihael Hristos Polymeropoulos
President, Chief Executive Officer & Director
H. Thomas Watkins
Chairman